[1]
M. K. A. Aal, M. B. Nassar, E. Elgendy, and S. F. Badr, “Evaluation of Time in Therapeutic Range of Patients with Non-Valvular Atrial Fibrillation on Oral Anticoagulation with Vitamin K Antagonist in Delta Region”, CA, vol. 10, no. 3, pp. 32-38, Jun. 2021.